In the present study, we screened the TCGA database to identify VSX1 as a novel oncogenic activator in ccRCC and demonstrated that VSX1 affected ccRCC aggressiveness in vitro. This evidence concerns the gene VSX1 and nonpapillary renal cell carcinoma.